×
Syra Health Price to Free Cash Flow Ratio 2022-2024 | SYRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Syra Health price to free cash flow ratio from 2022 to 2024. Price to free cash flow ratio can be defined as
View More
Syra Health Price to Free Cash Flow Ratio 2022-2024 | SYRA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Syra Health price to free cash flow ratio from 2022 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Tempus AI (TEM)
$9.2B
Inspire Medical Systems (INSP)
$5.7B
Hims & Hers Health (HIMS)
$5.5B
Enovis (ENOV)
$2.6B
Privia Health (PRVA)
$2.6B
IRhythm Technologies (IRTC)
$2.3B
Azenta (AZTA)
$2.2B
Omnicell (OMCL)
$2.1B
10x Genomics (TXG)
$1.7B
Clover Health Investments (CLOV)
$1.7B
Schrodinger (SDGR)
$1.5B
Phreesia (PHR)
$1.1B
Butterfly Network (BFLY)
$690M
Standard BioTools (LAB)
$596M
Talkspace (TALK)
$583M
Fulgent Genetics (FLGT)
$547M
Definitive Healthcare (DH)
$505M
Health Catalyst (HCAT)
$495M
Pulmonx (LUNG)
$268M
TruBridge (TBRG)
$247M
SOPHiA GENETICS SA (SOPH)
$209M
American Well (AMWL)
$124M
EUDA Health Holdings (EUDA)
$112M
P3 Health Partners (PIII)
$76M
HeartBeam (BEAT)
$74M
111 (YI)
$52M
CareCloud (CCLD)
$46M
Outset Medical (OM)
$44M
SHL Telemedicine (SHLT)
$42M
Zepp Health (ZEPP)
$37M